Developing research leaders at the intersection of malnutrition and tuberculosis in Tanzania

培养坦桑尼亚营养不良和结核病交叉领域的研究领导者

基本信息

  • 批准号:
    10588197
  • 负责人:
  • 金额:
    $ 24.83万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-03-01 至 2027-02-28
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY / ABSTRACT This application for a new Global Infectious Diseases Research Training program (GIDRTP) at the University of Virginia (UVA) extends decades of training global leaders in diseases of poverty and infectious diseases through cycles of support of International Training and Research in Emerging Infectious Diseases, Actions for Building Capacity, Minority Health International Research Training, and Fogarty GIDRTPs. These prior experiences provide lessons learned and tested mechanisms for developing trainees into independent public health scientists. Despite the prior focus on early stage trainees such as undergraduate, Masters or doctoral students, we have noted unique barriers in progression through postdoctoral training to research leadership in Tanzania. We performed a needs assessment among Tanzanian postdoctoral scientists in 2021 which confirmed this observation and outlined gaps and opportunities with which to structure a postdoctoral focused GIDRTP. UVA, the Division of Infectious Diseases and International Health, and the Center for Global Health Equity have been at the forefront of research and training in malnutrition and its infectious consequences for decades. In non- pandemic periods, tuberculosis (TB) is the leading killer from a curable infectious disease. COVID-19 has further disrupted TB care and is projected to increase deaths from TB by 20% over the next five years. Malnutrition, both undernutrition and poor nutrition leading to conditions such as diabetes mellitus, is the most important driver of TB disease globally. Therefore, this GIDRTP aims to strengthen existing educational and research linkages with the UVA and the Kilimanjaro Christian Medical University College/ Kilimanjaro Clinical Research Institute (KCMUCo/KCRI) in Tanzania, to support Tanzanian postdoctoral trainees' growth to research leaders working at the intersection of malnutrition and TB. We aim to train 6 postdoctoral scientists with 3 years of support each through an individualized research leadership plan based on the framework of the Path to Research Leadership in Africa Report (2020). In addition to matching postdoctoral fellows to Tanzanian and UVA mentors, the individualized research leadership plan will include assessment by Lead Educators and core programmatic faculty including a biostatistician to design personalized coursework and skills building toward the metric categories of research team management, communication, grant writing, professionalism and career trajectory. We will harness the current infrastructure of funding from the National Institutes of Health, Bill and Melinda Gates Foundation, European and Developing Countries Trials Partnership, World Health Organization and the Danish Ministry of Foreign Affairs for TB and malnutrition research in Tanzania, and we expect to launch the careers of junior scientists and content leaders that will compete for independent funding, set research agendas, make policy and benefit their communities in- line with the World Health Organization's End TB Strategy.
项目概要/摘要 这份申请是为英国大学新的全球传染病研究培训计划 (GIDRTP) 弗吉尼亚州 (UVA) 延续了数十年对贫困疾病和传染病领域全球领导者的培训 新发传染病国际培训和研究的支持周期、建设行动 能力、少数民族健康国际研究培训和福格蒂 GIDRTP。这些之前的经历 提供经验教训和经过测试的机制,将受训者培养成独立的公共卫生人员 科学家。尽管之前的重点是本科生、硕士生或博士生等早期学员, 我们注意到坦桑尼亚通过博士后培训晋升为研究领导者的独特障碍。 我们于 2021 年对坦桑尼亚博士后科学家进行了需求评估,证实了这一点 观察并概述了构建以博士后为重点的 GIDRTP 的差距和机会。长波紫外线, 传染病和国际卫生司以及全球卫生公平中心 数十年来一直处于营养不良及其传染性后果研究和培训的前沿。在非 大流行期间,结核病 (TB) 是可治愈传染病的头号杀手。 COVID-19 进一步 结核病护理受到干扰,预计未来五年内结核病死亡人数将增加 20%。营养不良, 营养不足和营养不良导致糖尿病等疾病,是最重要的驱动因素 全球结核病的发病率。因此,GIDRTP 旨在加强现有的教育和研究联系 与 UVA 和乞力马扎罗基督教医科大学学院/乞力马扎罗临床研究所合作 (KCMUCo/KCRI)在坦桑尼亚,支持坦桑尼亚博士后学员成长为研究领导者 处于营养不良和结核病的交叉点。 我们的目标是通过个性化研究培养 6 名博士后科学家,每人提供 3 年的支持 基于非洲研究领导力之路报告(2020)框架的领导力计划。此外 为了将博士后研究员与坦桑尼亚和 UVA 导师相匹配,个性化的研究领导计划将 包括首席教育者和核心课程教师的评估,包括生物统计学家的设计 针对研究团队管理的指标类别进行个性化课程和技能建设, 沟通、资助写作、专业精神和职业轨迹。我们将利用现有的基础设施 来自美国国立卫生研究院、比尔和梅琳达·盖茨基金会、欧洲和发展中国家的资助 国家试验伙伴关系、世界卫生组织和丹麦外交部结核病和 坦桑尼亚的营养不良研究,我们期望启动初级科学家和内容领导者的职业生涯 他们将争夺独立资金、制定研究议程、制定政策并造福于他们的社区—— 符合世界卫生组织的终结结核病战略。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Scott K Heysell其他文献

Scott K Heysell的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Scott K Heysell', 18)}}的其他基金

Developing research leaders at the intersection of malnutrition and tuberculosis in Tanzania
培养坦桑尼亚营养不良和结核病交叉领域的研究领导者
  • 批准号:
    10461564
  • 财政年份:
    2022
  • 资助金额:
    $ 24.83万
  • 项目类别:
Developing research leaders at the intersection of malnutrition and tuberculosis in Tanzania
培养坦桑尼亚营养不良和结核病交叉领域的研究领导者
  • 批准号:
    10875013
  • 财政年份:
    2022
  • 资助金额:
    $ 24.83万
  • 项目类别:
A randomized clinical trial of early empiric anti-Mycobacterium tuberculosis therapy for sepsis in sub-Saharan Africa
撒哈拉以南非洲地区早期经验性抗结核杆菌治疗败血症的随机临床试验
  • 批准号:
    10084642
  • 财政年份:
    2020
  • 资助金额:
    $ 24.83万
  • 项目类别:
A randomized clinical trial of early empiric anti-Mycobacterium tuberculosis therapy for sepsis in sub-Saharan Africa
撒哈拉以南非洲地区早期经验性抗结核杆菌治疗败血症的随机临床试验
  • 批准号:
    10443820
  • 财政年份:
    2020
  • 资助金额:
    $ 24.83万
  • 项目类别:
A randomized clinical trial of early empiric anti-Mycobacterium tuberculosis therapy for sepsis in sub-Saharan Africa
撒哈拉以南非洲地区早期经验性抗结核杆菌治疗败血症的随机临床试验
  • 批准号:
    10653094
  • 财政年份:
    2020
  • 资助金额:
    $ 24.83万
  • 项目类别:
A randomized clinical trial of early empiric anti-Mycobacterium tuberculosis therapy for sepsis in sub-Saharan Africa
撒哈拉以南非洲地区早期经验性抗结核杆菌治疗败血症的随机临床试验
  • 批准号:
    10265511
  • 财政年份:
    2020
  • 资助金额:
    $ 24.83万
  • 项目类别:
Urine Colorimetry for Tuberculosis Pharmacokinetics Evaluation in Children and Adults
尿液比色法用于儿童和成人结核病药代动力学评价
  • 批准号:
    10168710
  • 财政年份:
    2018
  • 资助金额:
    $ 24.83万
  • 项目类别:
Urine Colorimetry for Tuberculosis Pharmacokinetics Evaluation in Children and Adults
尿液比色法用于儿童和成人结核病药代动力学评价
  • 批准号:
    10221522
  • 财政年份:
    2018
  • 资助金额:
    $ 24.83万
  • 项目类别:
Urine Colorimetry for Tuberculosis Pharmacokinetics Evaluation in Children and Adults
尿液比色法用于儿童和成人结核病药代动力学评价
  • 批准号:
    10245319
  • 财政年份:
    2018
  • 资助金额:
    $ 24.83万
  • 项目类别:
Urine Colorimetry for Tuberculosis Pharmacokinetics Evaluation in Children and Adults
尿液比色法用于儿童和成人结核病药代动力学评价
  • 批准号:
    10320620
  • 财政年份:
    2018
  • 资助金额:
    $ 24.83万
  • 项目类别:

相似国自然基金

CEACAM5调控Galectin-9介导的CD4+T细胞极化在COVID-19肠屏障损伤的作用机制研究
  • 批准号:
    82370569
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
基于异构化数据和图神经网络预测新冠肺炎患者恢复期肺功能的研究
  • 批准号:
    82302313
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于 GDF15-IL6 信号轴探究扶正解毒方逆转血管内皮衰老治疗COVID-19的作用与机制
  • 批准号:
    82374392
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目
SARS-CoV-2病毒编码的miR-nsp3-3p和miR-ORF10-5p协同调控COVID-19重症转化机制及临床价值研究
  • 批准号:
    82372342
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目

相似海外基金

An interactive, narrative intervention to address the mental health treatment gap among young people living with HIV in Nigeria
一种互动式叙事干预措施,旨在解决尼日利亚艾滋病毒感染者年轻人的心理健康治疗差距
  • 批准号:
    10914342
  • 财政年份:
    2023
  • 资助金额:
    $ 24.83万
  • 项目类别:
AHOMKA: A Culturally-adapted mHealth Platform for Management of Hypertension in an Urban and Rural Region of Ghana
AHOMKA:一个适应文化的移动医疗平台,用于加纳城乡地区的高血压管理
  • 批准号:
    10889289
  • 财政年份:
    2023
  • 资助金额:
    $ 24.83万
  • 项目类别:
New pathways to prevention from community TB screening in South Africa
南非社区结核病筛查预防的新途径
  • 批准号:
    10760095
  • 财政年份:
    2023
  • 资助金额:
    $ 24.83万
  • 项目类别:
Implementing and Evaluating the Cancer Tracking System (CATSystem): A systems level intervention to improve Cervical Cancer screening, treatment referral and follow up in Kenya
实施和评估癌症追踪系统 (CATSystem):系统级干预措施,旨在改善肯尼亚的宫颈癌筛查、治疗转诊和随访
  • 批准号:
    10762689
  • 财政年份:
    2023
  • 资助金额:
    $ 24.83万
  • 项目类别:
Impact of gestational SARS-CoV-2 and maternal inflammation on child growth and neurodevelopment in a malaria-endemic setting
疟疾流行环境中妊娠期 SARS-CoV-2 和母体炎症对儿童生长和神经发育的影响
  • 批准号:
    10722878
  • 财政年份:
    2023
  • 资助金额:
    $ 24.83万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了